Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia [Phase 3]
Phase 3 trial update comparing consolidation strategies for pediatric acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating natural killer cells as part of donor stem cell transplantation for various myeloid leukemias and myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 trial evaluating allogeneic hematopoietic stem cell transplantation as initial salvage therapy for induction failure in acute myeloi…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating an antigen-specific T cell therapy for patients with acute myeloid leukemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: FLYSYN in MRD Positive AML [Phase 1, Phase 2]
Clinical trial update for FLYSYN in MRD-positive acute myeloid leukemia completed phases 1 and 2.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial of NTLA-5001 in Acute Myeloid Leukemia has been terminated; results posted previously.
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia [Phase 3]
A Phase 3 bridging study evaluating liposomal cytarabine-daunorubicin for older patients with treatment-naive high-risk secondary acute myel…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML [Phase 1, Phase 2]
Pilot study results for crenolanib combined with salvage chemotherapy in relapsed/refractory acute myeloid leukemia (AML) reported in a Phas…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML [Phase 3]
Phase 3 continuation study of azacitidine with or without glasdegib in untreated AML, MDS, or CMML; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients [Phase 2]
Phase 2 trial update evaluating crenolanib as maintenance therapy after allogeneic stem cell transplantation in FLT3-positive acute myeloid …
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Flotetuzumab for the Treatment of Pediatric Recurrent or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial of Flotetuzumab in pediatric patients with recurrent or refractory acute myeloid leukemia; results were posted in Dec…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: 8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
A phase 1/2 clinical trial investigates 8-Chloroadenosine for relapsed or refractory acute myeloid leukemia, with completed results posted i…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations [Phase 2]
Phase II study of crenolanib in relapsed/refractory FLT3-mutated acute myeloid leukemia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating CART-19 T cell therapy targeting CD19 in patients with relapsed or refractory acute myeloid leukemia (…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression [Phase 2, Phase 3]
A clinical trial update involving CAR-T therapy targeting CD19 for acute myeloid leukemia across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies [Phase 2]
Phase 2 clinical trial evaluating venetoclax plus reduced-intensity conditioning allogeneic stem cell transplantation in elderly patients wi…
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Bisantrene Combination for Resistant AML [Phase 2]
Phase 2 clinical trial update for a bisantrene combination in resistant acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical study evaluating venetoclax in combination with CAG for refractory/relapsed acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT [Phase 2]
Phase 2 clinical trial update evaluating plerixafor in combination with donor lymphocyte infusion for relapsed acute leukemia after allogene…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant [Phase 2]
Phase II clinical trial in elderly patients with acute myeloid leukemia or myelodysplastic syndromes in complete remission not eligible for …
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [Phase 2]
Phase 2 pediatric trial evaluating Isatuximab in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia or acute…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor natural killer cells and donor stem cell transplant in high-risk myeloid malignancies; completed w…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS [Phase 2]
Phase 2 trial update of multi-modality treatment with Ruxolitinib, Decitabine, and donor lymphocyte infusion after stem cell transplant in A…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1]
Phase 1 trial of milademetan in Japanese patients with relapsed or refractory acute myeloid leukemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT [Phase 2]
Phase 2 trial investigating relapse prophylaxis with N-803 after allogeneic HSCT in AML and MDS patients has completed with posted results.